These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

559 related items for PubMed ID: 24374027

  • 1. A new classification system for chronic lung allograft dysfunction.
    Verleden GM, Raghu G, Meyer KC, Glanville AR, Corris P.
    J Heart Lung Transplant; 2014 Feb; 33(2):127-33. PubMed ID: 24374027
    [Abstract] [Full Text] [Related]

  • 2. Current views on chronic rejection after lung transplantation.
    Verleden GM, Vos R, Vanaudenaerde B, Dupont L, Yserbyt J, Van Raemdonck D, Verleden S.
    Transpl Int; 2015 Oct; 28(10):1131-9. PubMed ID: 25857869
    [Abstract] [Full Text] [Related]

  • 3. Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS).
    Verleden SE, Vandermeulen E, Ruttens D, Vos R, Vaneylen A, Dupont LJ, Van Raemdonck DE, Vanaudenaerde BM, Verleden GM.
    Semin Respir Crit Care Med; 2013 Jun; 34(3):352-60. PubMed ID: 23821509
    [Abstract] [Full Text] [Related]

  • 4. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
    Sato M, Waddell TK, Wagnetz U, Roberts HC, Hwang DM, Haroon A, Wagnetz D, Chaparro C, Singer LG, Hutcheon MA, Keshavjee S.
    J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
    [Abstract] [Full Text] [Related]

  • 5. Validation of a post-transplant chronic lung allograft dysfunction classification system.
    Van Herck A, Verleden SE, Sacreas A, Heigl T, Vanaudenaerde BM, Dupont LJ, Yserbyt J, Verbeken EK, Neyrinck AP, Van Raemdonck D, Verleden GM, Vos R.
    J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
    [Abstract] [Full Text] [Related]

  • 6. Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal?
    Verleden GM, Dupont LJ, Van Raemdonck DE.
    Eur Respir J; 2005 Feb; 25(2):221-4. PubMed ID: 15684284
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
    Todd JL, Neely ML, Finlen Copeland CA, Frankel CW, Reynolds JM, Palmer SM.
    J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
    [Abstract] [Full Text] [Related]

  • 8. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?
    Verleden SE, Ruttens D, Vandermeulen E, Vaneylen A, Dupont LJ, Van Raemdonck DE, Verleden GM, Vanaudenaerde BM, Vos R.
    Transplantation; 2013 May 15; 95(9):1167-72. PubMed ID: 23425818
    [Abstract] [Full Text] [Related]

  • 9. Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection.
    Vos R, Vanaudenaerde BM, Verleden SE, Ruttens D, Vaneylen A, Van Raemdonck DE, Dupont LJ, Verleden GM.
    Transplantation; 2012 Jul 27; 94(2):101-9. PubMed ID: 22461039
    [Abstract] [Full Text] [Related]

  • 10. Time-dependent changes in the risk of death in pure bronchiolitis obliterans syndrome (BOS).
    Sato M, Ohmori-Matsuda K, Saito T, Matsuda Y, Hwang DM, Waddell TK, Singer LG, Keshavjee S.
    J Heart Lung Transplant; 2013 May 27; 32(5):484-91. PubMed ID: 23433813
    [Abstract] [Full Text] [Related]

  • 11. Reliability of diagnostic criteria for bronchiolitis obliterans syndrome after lung transplantation: a survey.
    Kapila A, Baz MA, Valentine VG, Bhorade SM, AIRSAC investigators.
    J Heart Lung Transplant; 2015 Jan 27; 34(1):65-74. PubMed ID: 25447585
    [Abstract] [Full Text] [Related]

  • 12. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation.
    Cooper JD, Billingham M, Egan T, Hertz MI, Higenbottam T, Lynch J, Mauer J, Paradis I, Patterson GA, Smith C.
    J Heart Lung Transplant; 1993 Jan 27; 12(5):713-6. PubMed ID: 8241207
    [Abstract] [Full Text] [Related]

  • 13. Obliterative bronchiolitis following lung transplantation: from old to new concepts?
    Verleden GM, Vos R, De Vleeschauwer SI, Willems-Widyastuti A, Verleden SE, Dupont LJ, Van Raemdonck DE, Vanaudenaerde BM.
    Transpl Int; 2009 Aug 27; 22(8):771-9. PubMed ID: 19490538
    [Abstract] [Full Text] [Related]

  • 14. The Lymphatic Phenotype of Lung Allografts in Patients With Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome.
    Traxler D, Schweiger T, Schwarz S, Schuster MM, Jaksch P, Lang G, Birner P, Klepetko W, Ankersmit HJ, Hoetzenecker K.
    Transplantation; 2017 Feb 27; 101(2):310-315. PubMed ID: 27163544
    [Abstract] [Full Text] [Related]

  • 15. Prophylactic Azithromycin Therapy After Lung Transplantation: Post hoc Analysis of a Randomized Controlled Trial.
    Ruttens D, Verleden SE, Vandermeulen E, Bellon H, Vanaudenaerde BM, Somers J, Schoonis A, Schaevers V, Van Raemdonck DE, Neyrinck A, Dupont LJ, Yserbyt J, Verleden GM, Vos R.
    Am J Transplant; 2016 Jan 27; 16(1):254-61. PubMed ID: 26372728
    [Abstract] [Full Text] [Related]

  • 16. A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy.
    Vanaudenaerde BM, Meyts I, Vos R, Geudens N, De Wever W, Verbeken EK, Van Raemdonck DE, Dupont LJ, Verleden GM.
    Eur Respir J; 2008 Oct 27; 32(4):832-43. PubMed ID: 18827151
    [Abstract] [Full Text] [Related]

  • 17. Chronic lung allograft dysfunction after lung transplantation: the moving target.
    Sato M.
    Gen Thorac Cardiovasc Surg; 2013 Feb 27; 61(2):67-78. PubMed ID: 23138970
    [Abstract] [Full Text] [Related]

  • 18. Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation.
    Suwara MI, Vanaudenaerde BM, Verleden SE, Vos R, Green NJ, Ward C, Borthwick LA, Vandermeulen E, Lordan J, Van Raemdonck DE, Corris PA, Verleden GM, Fisher AJ.
    Transpl Int; 2014 Aug 27; 27(8):857-67. PubMed ID: 24750386
    [Abstract] [Full Text] [Related]

  • 19. Managing bronchiolitis obliterans syndrome (BOS) and chronic lung allograft dysfunction (CLAD) in children: what does the future hold?
    Snell GI, Paraskeva M, Westall GP.
    Paediatr Drugs; 2013 Aug 27; 15(4):281-9. PubMed ID: 23605986
    [Abstract] [Full Text] [Related]

  • 20. Revisiting the pathologic finding of diffuse alveolar damage after lung transplantation.
    Sato M, Hwang DM, Ohmori-Matsuda K, Chaparro C, Waddell TK, Singer LG, Hutcheon MA, Keshavjee S.
    J Heart Lung Transplant; 2012 Apr 27; 31(4):354-63. PubMed ID: 22330935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.